Related references
Note: Only part of the references are listed.European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas
Gerald Raverot et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Welcoming the new WHO classification of pituitary tumors 2017: revolution in TTF-1-positive posterior pituitary tumors
Makoto Shibuya
BRAIN TUMOR PATHOLOGY (2018)
Risk category system to identify pituitary adenoma patients with AIP mutations
Francisca Caimari et al.
JOURNAL OF MEDICAL GENETICS (2018)
From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal
S. L. Asa et al.
ENDOCRINE-RELATED CANCER (2017)
Estrogen Receptor α, a Sex-Dependent Predictor of Aggressiveness in Nonfunctioning Pituitary Adenomas: SSTR and Sex Hormone Receptor Distribution in NFPA
Kristin Astrid Oystese et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Risk of Recurrence in Pituitary Neuroendocrine Tumors: A Prospective Study Using a Five-Tiered Classification
Gerald Raverot et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
The 2017 World Health Organization classification of tumors of the pituitary gland: a summary
M. Beatriz S. Lopes
ACTA NEUROPATHOLOGICA (2017)
Overview of the 2017 WHO Classification of Pituitary Tumors
Ozgur Mete et al.
ENDOCRINE PATHOLOGY (2017)
Genetics of Cushing's disease: update
L. G. Perez-Rivas et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2016)
Predictors of aggressive clinical phenotype among immunohistochemically confirmed atypical adenomas
Hasan A. Zaidi et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2016)
Functional Gonadotroph Adenomas: Case Series and Report of Literature
David J. Cote et al.
NEUROSURGERY (2016)
A Prognostic Clinicopathologic Classification of Pituitary Endocrine Tumors
Gerald Raverot et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2015)
Gene and protein expression in pituitary corticotroph adenomas: a systematic review of the literature
Justin Seltzer et al.
NEUROSURGICAL FOCUS (2015)
Null Cell Adenomas of the Pituitary Gland: an Institutional Review of Their Clinical Imaging and Behavioral Characteristics
James A. Balogun et al.
ENDOCRINE PATHOLOGY (2015)
Descriptive epidemiology of pituitary tumors in the United States, 2004-2009
Haley Gittleman et al.
JOURNAL OF NEUROSURGERY (2014)
A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up
Jacqueline Trouillas et al.
ACTA NEUROPATHOLOGICA (2013)
Germline mutations of AIP gene in somatotropinomas resistant to somatostatin analogues
Josep Oriola et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2013)
AIP expression in sporadic somatotropinomas is a predictor of the response to octreotide LAR therapy independent of SSTR2 expression
Leandro Kasuki et al.
ENDOCRINE-RELATED CANCER (2012)
Atypical pituitary adenomas: incidence, clinical characteristics, and implications Clinical article
Gabriel Zada et al.
JOURNAL OF NEUROSURGERY (2011)
Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line AIP Mutations and Pituitary Adenomas: An International Collaborative Study
Adrian F. Daly et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Pathobiology of pituitary adenomas and carcinomas
Bernd W. Scheithauer et al.
NEUROSURGERY (2006)
The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery
BP Meij et al.
JOURNAL OF NEUROSURGERY (2002)
Share Paper
